Robert M. Walton Appointed Chief Operating Officer at Oncology Analytics, Inc.

Tools

Robert M. Walton Appointed Chief Operating Officer at Oncology Analytics, Inc.

Oncology Analytics, Inc.

danielle@oncologyanalytics.com

Oncology Analytics, Inc. announced the addition of Robert M. Walton to its executive team as Chief Operating Officer and to its Board of Directors.

Marc Fishman, MD, the CEO of Oncology Analytics said, “we are honored to have a person of Mr. Walton’s proven talent and experience join us in our mission to improve cancer care quality while reducing unnecessary costs. He will be an invaluable asset as we expand into new markets nationwide.“

Prior to joining Oncology Analytics, Mr. Walton served as the President of Qualcomm Enterprise Services. He has also been Senior Vice President of National Healthplan Administration at Kaiser Permanente, a global Vice President at Compaq Computer and a national Vice President for Cigna Healthcare. At Oncology Analytics, Mr. Walton will oversee all business functions including marketing, sales, commercial research and development, IT and client services.

“I’m honored to be joining Dr. Fishman and the entire team at Oncology Analytics (OA), and excited to be able to contribute to the continued growth and success of the company. OA’s approach to utilization management and its business model are incredibly compelling to me. I believe that they set a standard for how cancer care should be managed in this country to improve outcomes, support data-based decisions, enhance the patient experience and reduce unnecessary costs.”

Mr. Walton holds a BA from the University of South Florida and a Master’s Degree from the University of Miami in Coral Gables, Florida. He is also a graduate of executive development programs at the Stanford Graduate School of Business in Palo Alto, California and the Harvard Business School in Cambridge, Massachusetts.

Oncology Analytics (OA) provides web-based clinical decision support tools to provide oncologists the essential knowledge to optimally use cancer drugs based on the best available evidence and nationally recognized guidelines. OA also provides cancer patients and their physicians with the added support of a team of board certified oncologists and support staff to ensure that physicians are providing the best and most cost-effective treatment plan for each patient. An active board of six practicing board certified oncologists as well as a distinguished academic advisory board of eight renowned cancer subspecialists back up these local resources. All these resources are available in real time to physicians. In addition to improving the quality of care, OA’s patented system of utilization management can diminish pharmaceutical costs by 40%, or more.

For more information, visit us on our website at , or call 888-916-2616.